Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Recursion Pharmaceuticals, Inc. RXRX

Full chart Compare
Set alert

Price alert · RXRX

All alert types
3.88 USD +0.20 (+5.43%)

At closeNov 4, 2026, 7:56 PM EST

3.85 -0.03 -0.77%

After hours · Nov 4, 7:56 PM ET

3.72 Day range 4.01
2.84 52-week range 5.00
YTD
-5.13%
1 year
-22.40%

Financial health

Altman Z-Score

0.62 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -2.8×
FY 2019: -48.2×FY 2020: -34.3×FY 2021: -16.3×FY 2022: -5.7×FY 2023: -6.2×FY 2024: -4.0×FY 2025: -2.8×
FY 2019 5y median -5.7× FY 2025
P/S 24.5×
FY 2019: 1744×FY 2020: 874×FY 2021: 292×FY 2022: 34.1×FY 2023: 46.7×FY 2024: 31.5×FY 2025: 24.5×
FY 2019 5y median 34.1× FY 2025
P/B 1.6×
FY 2019: -24.0×FY 2020: -14.5×FY 2021: 5.4×FY 2022: 2.8×FY 2023: 4.4×FY 2024: 1.8×FY 2025: 1.6×
FY 2019 5y median 2.8× FY 2025
P/FCF -4.8×
FY 2019: -49.0×FY 2020: -57.2×FY 2021: -14.7×FY 2022: -11.2×FY 2023: -6.8×FY 2024: -5.0×FY 2025: -4.8×
FY 2019 5y median -6.8× FY 2025
EV/EBITDA -2.1×
FY 2019: -49.3×FY 2020: -33.5×FY 2021: -15.1×FY 2022: -3.8×FY 2023: -5.6×FY 2024: -3.2×FY 2025: -2.1×
FY 2019 5y median -3.8× FY 2025
EV/Sales 15.6×
FY 2019: 1713×FY 2020: 802×FY 2021: 264×FY 2022: 21.5×FY 2023: 38.9×FY 2024: 23.2×FY 2025: 15.6×
FY 2019 5y median 23.2× FY 2025
FCF Yield -20.7%
FY 2019: -2.0%FY 2020: -1.7%FY 2021: -6.8%FY 2022: -8.9%FY 2023: -14.7%FY 2024: -20.1%FY 2025: -20.7%
FY 2019 5y median -14.7% FY 2025

Profitability

Gross Margin -62.0%
FY 2019: -2577.3%FY 2020: 100.0%FY 2021: 100.0%FY 2022: -21.7%FY 2023: 2.9%FY 2024: 23.1%FY 2025: -62.0%
FY 2019 5y median 2.9% FY 2025
Operating Margin -867.9%
FY 2019: -3649.4%FY 2020: -2479.2%FY 2021: -1827.8%FY 2022: -619.3%FY 2023: -797.8%FY 2024: -814.1%FY 2025: -867.9%
FY 2019 5y median -814.1% FY 2025
Net Margin -863.4%
FY 2019: -3654.3%FY 2020: -2549.3%FY 2021: -1864.8%FY 2022: -603.5%FY 2023: -747.7%FY 2024: -788.0%FY 2025: -863.4%
FY 2019 5y median -788.0% FY 2025
ROE -57.0%
FY 2019: 50.3%FY 2020: 42.2%FY 2021: -34.3%FY 2022: -49.3%FY 2023: -70.8%FY 2024: -44.8%FY 2025: -57.0%
FY 2019 5y median -49.3% FY 2025
ROIC -48.1%
FY 2019: -65.5%FY 2020: -30.5%FY 2021: -32.3%FY 2022: -40.5%FY 2023: -61.0%FY 2024: -37.2%FY 2025: -48.1%
FY 2019 5y median -40.5% FY 2025
ROA -43.7%
FY 2019: -61.6%FY 2020: -29.1%FY 2021: -30.6%FY 2022: -34.1%FY 2023: -50.2%FY 2024: -32.0%FY 2025: -43.7%
FY 2019 5y median -34.1% FY 2025

Growth (YoY)

Revenue 26.9%
FY 2019: 0.0%FY 2020: 99.5%FY 2021: 193.0%FY 2022: 296.8%FY 2023: 10.6%FY 2024: 34.1%FY 2025: 26.9%
FY 2019 FY 2025
Operating Income -35.3%
FY 2019: 0.0%FY 2020: -35.5%FY 2021: -116.0%FY 2022: -34.4%FY 2023: -42.5%FY 2024: -36.8%FY 2025: -35.3%
FY 2019 FY 2025
EPS (diluted) 14.8%
FY 2019: 0.0%FY 2020: -40.6%FY 2021: -100.1%FY 2022: -29.5%FY 2023: -16.2%FY 2024: -7.0%FY 2025: 14.8%
FY 2019 FY 2025
Free Cash Flow -1.5%
FY 2019: 0.0%FY 2020: 14.5%FY 2021: -280.6%FY 2022: 39.1%FY 2023: -148.4%FY 2024: -24.2%FY 2025: -1.5%
FY 2019 FY 2025

Financial Health

Current Ratio 5.5×
FY 2019: 11.4×FY 2020: 11.5×FY 2021: 11.5×FY 2022: 5.7×FY 2023: 4.7×FY 2024: 3.8×FY 2025: 5.5×
FY 2019 5y median 5.5× FY 2025
Quick Ratio 5.5×
FY 2019: 11.4×FY 2020: 11.5×FY 2021: 11.5×FY 2022: 5.7×FY 2023: 4.7×FY 2024: 3.8×FY 2025: 5.5×
FY 2019 5y median 5.5× FY 2025
Debt / Equity 0.1×
FY 2019: -0.1×FY 2020: -0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 1.2×
FY 2019: 0.9×FY 2020: 3.0×FY 2021: 1.6×FY 2022: 2.2×FY 2023: 1.1×FY 2024: 1.1×FY 2025: 1.2×
FY 2019 5y median 1.2× FY 2025
Interest Coverage -358×
FY 2019: -98.3×FY 2020: -62.2×FY 2021: -61.9×FY 2022: -4468×FY 2023: -3609×FY 2024: -305×FY 2025: -358×
FY 2019 5y median -358× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31